close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Filana Therapeutics, Inc. - Common Stock (NQ:FLNA)

0.8788 -0.1512 (-14.68%)
Streaming Delayed Price Updated: 1:02 PM EDT, Sep 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Filana Therapeutics, Inc. - Common Stock

News headline image
Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy
From Filana Therapeutics, Inc.
Via GlobeNewswire
News headline image
Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
From Filana Therapeutics, Inc.
Via GlobeNewswire
News headline image
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
From Filana Therapeutics, Inc.
Via GlobeNewswire
News headline image
Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII
Presentation described the biological rationale for the evaluation of simufilam in TSC-related epilepsy 
From Filana Therapeutics, Inc.
Via GlobeNewswire
News headline image
Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data
From Filana Therapeutics, Inc.
Via GlobeNewswire
News headline image
Filana Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Working to advance TSC-related epilepsy program, with a focus on capital efficiency 
From Filana Therapeutics, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.